Skip to main content

Table 1 Comparison of clinical characteristics in patients with cyst rupture (CR) and without CR

From: Does intraoperative cyst rupture of malignant cystic renal masses really have no negative impact on oncologic outcomes?

Variables

nonCR

CR

p-value

No. of patients

374

32

 

No. of recurrence (%)

5 (1.3)

4 (12.5)

0.003

Mean ± SD age (range) (years)

52.94 ± 13.37 (15–85)

54.91 ± 12.78 (30–83)

0.423

Mean ± SD BMI (range) (kg/m2)

24.61 ± 3.40 (16.2–36.2)

23.92 ± 3.18 (18.8–29.8)

0.273

Mean ± SD RENAL score

7.18 ± 1.66 (4–11)

7.28 ± 1.63 (4–10)

0.752

Mean ± SD tumor size (cm)

2.94 ± 1.21 (1.0–8.0)

3.42 ± 1.77 (1.5–8.0)

0.139

No. of hypertension (%)

120 (32.1)

9 (28.1)

0.664

No. of diabetes (%)

55 (14.7)

8 (25.0)

0.147

No. of smoking (%)

67 (17.9)

7 (21.9)

0.578

Mean ± SD eGFR (range) (ml/min)

104.84 ± 11.3 (73–119)

101.85 ± 10.31 (75–118)

0.147

No. gender (%)

  

0.490

 Male

278 (74.3)

22 (68.8)

 

 Female

96 (25.7)

10 (31.3)

 

No. of tumor location (%)

  

0.107

 Left kidney

184 (49.2)

11 (34.4)

 

 Right kidney

190 (50.8)

21 (65.6)

 

No. of Bosniak classification (%)

  

< 0.001

 IIF

27 (7.2)

8 (25.0)

 

 III

174 (46.5)

20 (62.5)

 

 IV

173 (46.3)

4 (12.5)

 

No. of surgical approach (%)

  

0.119

 OPN

216 (57.8)

23 (71.9)

 

 MIPN

158 (42.2)

9 (28.1)

 

No. of Fuhrman classification (%)a

  

0.258

 I

40 (12.1)

5 (23.8)

 

 II

272 (82.2)

15 (71.4)

 

 III

19 (5.7)

1 (4.8)

 

 IV

0

0

 

No. of pathological type (%)

  

< 0.001

 ccRCC

298 (79.7)

14 (43.8)

 

 MCRNLMP

36 (9.6)

6 (18.8)

 

 pRCC

15 (4)

5 (15.6)

 

 cRCC

12 (3.2)

2 (6.3)

 

 othersb

13 (3.5)

5 (15.6)

 

No. of malignant potential (%)c

  

0.001

 High aggressiveness

304 (81.3)

18 (56.3)

 

 Low aggressiveness

70 (18.7)

14 (43.8)

 
  1. BMI body mass index, OPN open partial nephrectomy, MIPN minimally invasive partial nephrectomy, ccRCC clear cell renal cell carcinoma, MCRNLMP multilocular cystic renal neoplasm of low malignant potential, pRCC papillary renal cell carcinoma, cRCC chromophobe renal cell carcinoma
  2. accRCC, pRCC, cRCC, RCC, unclassified and clear cell papillary renal cell carcinomas were graded by Fuhrman classification
  3. bOthers include MiT family translocation RCC, RCC, unclassified, mixed epithelial and stromal tumor, clear cell papillary renal cell carcinomas, thyroid-like follicular RCC, metastatic tumor, and renal carcinosarcoma
  4. cccRCC, type II pRCC and renal carcinosarcoma were classified as high aggressiveness, and other pathologies were classified as low aggressiveness